| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Cash | — | 0.01 | 0.62 | 0.19 |
| Receivables | — | 0.29 | 0.01 | 0.01 |
| Inventory | — | 0.99 | 1.12 | 1.12 |
| Other | — | 0.60 | 0.41 | 0.24 |
| — | 2.07 | 2.59 | 1.75 |
| 2022 | 2023 | 2024 | Q'25 | |
|---|---|---|---|---|
| Payables | — | 2.29 | 1.48 | 1.13 |
| ST’ Debt | — | — | — | — |
| Other | — | 0.17 | 0.23 | 0.00 |
| — | 4.28 | 2.28 | 1.85 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | — |
| Earnings | — | — | — |
| Book Value | — | — | — |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’24 | — | — | — | — |
2.93
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | (1.10) | — | — |
—
|
| ’24 | — | — | — | (1.57) |
(1.58)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | (1.11) | — | — |
—
|
| ’24 | — | — | — | (1.58) |
(1.58)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 15.00 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | — | — | 83.75 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | — | 10 | 10 | — | — | — |
Employees
|
| — | — | — | — | — | — | — | — | 0.31 | 0.29 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | — | 3.15 | 2.93 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| — | — | — | — | — | — | — | — | 65.26% | 76.14% | — | — | — |
Gross Margin
|
| — | — | — | — | — | — | — | — | (2.26) | (3.06) | — | — | — |
EBT
|
| — | — | — | — | — | — | — | — | (71.64%) | (104.31%) | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| — | — | — | — | — | — | — | — | (2.01) | (2.57) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| — | — | — | — | — | — | — | — | 0.25 | 0.45 | — | — | — |
Depreciation
|
| — | — | — | — | — | — | — | — | 10.14 | 8.83 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| — | — | — | — | — | — | — | — | — | (7.75) | ‡‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| — | — | — | — | — | — | — | — | 0.19 | (4.74) | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | — | — | — | 0.00 | (0.02) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| — | — | — | — | — | — | — | — | 0.18 | (4.76) | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | — | — | — | 1.96 | 7.89 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | — | — | — | 0.31 | 0.33 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| — | — | — | — | — | — | — | — | — | — | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| — | — | — | — | — | — | — | — | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| — | — | — | — | — | — | — | — | 0.00 | 0.00 | ‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | — | — |
EV/FCF
|
| — | — | — | — | — | — | — | — | 0.06 | (1.58) | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | 0.00 | (0.01) | — | — | — |
Capex
|
| — | — | — | — | — | — | — | — | 0.06 | (1.58) | — | — | — |
FCF
|
| — | — | — | — | — | — | — | — | (2.21) | 0.31 | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Total Debt
|
| — | — | — | — | — | — | — | — | (0.01) | (0.62) | — | — | — |
Net Debt
|
| — | — | — | — | — | — | — | — | 0.61 | 2.62 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | — | — | — | 0.00% | (52.01%) | — | — | — |
ROA
|
| — | — | — | — | — | — | — | — | (224.92%) | (99.95%) | — | — | — |
ROIC
|
| — | — | — | — | — | — | — | — | 0.00% | (159.33%) | — | — | — |
ROE
|
Innovation Beverage Group Limited (IBG) embodies a high-risk microcap turnaround in the competitive beverage sector, marked by revenue volatility—dipping 7% to $2.93 million in 2024 despite gross margins expanding to 76%—persistent losses widening to -$2.57 million, and negative free cash flow signaling working capital strains. With lean operations (10 employees yielding high revenue per employee) and a cash-rich but thin balance sheet, the stock has endured extreme swings, plunging from 2024 peaks to multi-year troughs amid thinly traded momentum trading, now flashing deeply depressed valuations like a trailing P/E of -10x.
Analyst forecasts offer tantalizing upside: revenue doubling to $6 million in 2025 and $9 million in 2026, flipping to profitability with EPS at $0.11 and forward P/E of 4.56x, implying 2,400% mean price target surge. Yet, a 402% share dilution to 8.34 million overhangs per-share gains, while execution hurdles loom large—tripling sales without headcount growth, absent insider buying, partnerships, or proven catalysts, echoing faded hype in peers like Beyond Meat.
For risk-averse investors, IBG demands caution amid balance sheet fragility, cyclical risks, and no moat; it’s a speculative lottery ticket warranting tiny allocations, with downside to zero if projections falter—monitor for revenue beats or insider conviction to spark re-rating potential.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.